NCT07585578

Brief Summary

Over the past two decades, rapid advances in critical care medicine have markedly reduced short-term mortality among critically ill patients. As a result, a growing number of patients survive the acute phase of critical illness but do not recover quickly. Instead, they develop chronic critical illness (CCI), which is characterized by prolonged dependence on intensive care, including prolonged mechanical ventilation, persistent organ dysfunction, recurrent infections, and extended intensive care unit (ICU) stay. Patients with CCI have a heavy symptom burden and consume substantial healthcare resources, and many survivors experience persistent physical, cognitive, and psychological impairments after hospital discharge. Although CCI has gained increasing attention in recent years, existing studies still have multiple limitations. The number of patients with CCI in China continues to rise, and critical care delivery models vary widely across regions and healthcare institutions. There is therefore an urgent need for a large-scale multicenter observational study to systematically characterize the epidemiological features, multidimensional functional impairment profiles, and long-term functional outcomes of Chinese patients with CCI. The findings will provide an evidence-based foundation for developing a scientific post-ICU continuum of care for this population.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started May 2026

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
May 2026May 2027

First Submitted

Initial submission to the registry

May 1, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

May 12, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

October 16, 2026

Status Verified

October 1, 2026

Enrollment Period

8 months

First QC Date

May 1, 2026

Last Update Submit

October 13, 2026

Conditions

Keywords

Critical IllnessHigh-dependency unitfunctional outcome

Outcome Measures

Primary Outcomes (9)

  • MRC Sum Score for Muscle Strength

    MRC (Medical Research Council) sum score assessing muscle strength. Total score ranges from 0 (complete quadriplegia) to 60 (normal bilateral muscle strength). Higher scores indicate better muscle strength.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • ICU Mobility Scale Score

    ICU Mobility Scale (IMS) assessing mobility level in ICU patients. Total score ranges from 0 (lying in bed, not active) to 10 (walking independently). Higher scores indicate better mobility.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • Chelsea Critical Care Physical Assessment Tool Score

    Chelsea Critical Care Physical Assessment Tool (CPAx) comprehensively evaluating physical function in ICU patients. Total score ranges from 0 to 50. Higher scores indicate better physical function.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • Mini-Mental State Examination Score

    Mini-Mental State Examination (MMSE) assessing cognitive function. Total score ranges from 0 to 30. Higher scores indicate better cognitive function. (Chinese validated version will be used.)

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • PHQ-9 Score for Depression

    Patient Health Questionnaire-9 (PHQ-9) assessing severity of depressive symptoms. Total score ranges from 0 to 27 (0-4: none, 5-9: mild, 10-14: moderate, 15-19: moderately severe, 20-27: severe). Higher scores indicate worse depression.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • GAD-7 Score for Anxiety

    Generalized Anxiety Disorder 7-item scale (GAD-7) assessing severity of anxiety symptoms. Total score ranges from 0 to 21 (0-4: none, 5-9: mild, 10-14: moderate, 15-21: severe). Higher scores indicate worse anxiety.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • Pittsburgh Sleep Quality Index Global Score

    Pittsburgh Sleep Quality Index (PSQI) assessing sleep quality. Global score ranges from 0 to 21. Higher scores indicate worse sleep quality.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • Brief Pain Inventory-9 Pain Severity Score

    Brief Pain Inventory-9 (BPI-9) pain severity score. Total score ranges from 0 to 10. Higher scores indicate more severe pain.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

  • Hospital Anxiety and Depression Scale Score for Family Caregivers

    Hospital Anxiety and Depression Scale (HADS) assessing psychological status of family caregivers. Each subscale (anxiety and depression) ranges from 0 to 21. Higher scores indicate worse psychological distress.

    Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.

Study Arms (1)

Patients With Chronic Critical Illness

Adult patients with chronic critical illness (CCI) admitted to four participating high-dependency units (HDUs) in China.

Other: Data Collection and Assessment

Interventions

1. General clinical data collection: demographic characteristics, primary disease, duration of tracheostomy tube retention, duration of mechanical ventilation before transfer, and length of ICU stay before transfer; history of organ dysfunction; tube/catheter status; disease severity; nutritional status. 2. Physical function assessment: diaphragmatic excursion, diaphragm thickness, thickening fraction, PEF; Medical Research Council score for muscle strength, ICU Mobility Scale; comprehensive score: Chelsea Critical Care Physical Assessment Tool score. 3. Cognitive function assessment: Standardized Five Questions,Mini-Mental State Examination. 4. Psychological status assessment: Patient Health Questionnaire-9 for depression, Generalized Anxiety Disorder 7-item scale , Pittsburgh Sleep Quality Index, Brief Pain Inventory-9, Hospital Anxiety and Depression Scale for family caregivers. 5. Quality of life and functional capacity: Barthel Index, EQ-5D-5L.

Patients With Chronic Critical Illness

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This multicenter retrospective cross-sectional observational study included consecutive adults with chronic critical illness (CCI) transferred from ICUs to four participating high-dependency units (HDUs) in China between January 2018 and January 2026. CCI was defined as a post-ICU state in which patients no longer required full ICU-level care but remained clinically dependent, required continued HDU treatment, and could not be discharged directly home or return to community living. Data were obtained from routine medical, nursing, rehabilitation, and clinical records. Cognitive, physical, and psychological assessments were completed within 7 days of HDU admission, and family caregivers were assessed using the Hospital Anxiety and Depression Scale.

You may qualify if:

  • Adults aged 18 years or older.
  • Patients with chronic critical illness (CCI), operationally defined as patients transferred from an intensive care unit (ICU) to a participating high-dependency unit (HDU) who no longer required full ICU-level care but remained clinically dependent, required continued inpatient treatment in an HDU, and could not be discharged directly home or return to community living.
  • Completion of cognitive, physical, and psychological assessments within 7 days after HDU admission.

You may not qualify if:

  • No identifiable family caregiver available to complete the Hospital Anxiety and Depression Scale assessment.
  • A documented diagnosis of dementia or a chronic psychiatric disorder requiring continuous pharmacological treatment before the index ICU admission.
  • Admission to the HDU exclusively for end-of-life or palliative care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Anhui Wanbei Rehabilitation Hospital

Huaibei, Anhui, China

NOT YET RECRUITING

Beijing Rehabilitation Hospital, Capital Medical University, Beijing,China

Beijing, Beijing Municipality, 100043, China

RECRUITING

Hunan Rehabilitation Hospital

Hunan, Hunan, 410000, China

NOT YET RECRUITING

Zhengzhou Central Hospital Affiliated to Zhengzhou University

Henan, Zhengzhou, 450007, China

NOT YET RECRUITING

MeSH Terms

Conditions

Critical Illness

Interventions

Data CollectionRestraint, Physical

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthBehavior ControlTherapeuticsImmobilization

Central Study Contacts

Hongying Jiang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

May 1, 2026

First Posted

May 14, 2026

Study Start

May 12, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

May 31, 2027

Last Updated

October 16, 2026

Record last verified: 2026-10

Locations